PIP5K3 Peptide
€100.00
In stock
SKU
350536
Protein Family: Enzymes, Protein Kinases
Pathway and Disease: Carbohydrate Metabolism, Cell Motility, Signal Transduction
Alternate Names: FYVE finger-containing phosphoinositide kinase; 1-phosphatidylinositol-4-phosphate 5-kinase; Phosphatidylinositol-3-phosphate 5-kinase type III; PIP5K; PtdIns(4)P-5-kinase; PIKfyve; p235; PIP5K3
Accession No.: Q9Y2I7, NP_055855
Description:
The 1-phosphatidylinositol-4-phosphate 5-kinase (PIP5K3) supports the intracellular PIP and PI 4,5-P(2) pools by generating PIP from PI and PI 4,5-P(2) from PI 4-P. PIP5K3 is involved in endosome-related membrane trafficking. Defects in PIP5K3 are the cause of corneal fleck dystrophy.
Format:
Each vial contains 0.1 ml peptide in deionized water for a final concentration of 1 mg/ml. Use at 5.6 ug/ml for a 100X excess over antibody for maximum blocking effect.
MW: 1935 g/mol
Sequence:
The synthetic peptide used to raise the antibody Cat. No. 200174 is selected from a sequence within the N-term region of human PIP5K3. For blocking experiments, a 10 to 100 fold molar excess to antibody is recommended.
Composition:
C77H127N23O33S1
Purity:
> 80% by HPLC
Solubility:
Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile.
Storage:
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, store at -20°C.
Pathway and Disease: Carbohydrate Metabolism, Cell Motility, Signal Transduction
Alternate Names: FYVE finger-containing phosphoinositide kinase; 1-phosphatidylinositol-4-phosphate 5-kinase; Phosphatidylinositol-3-phosphate 5-kinase type III; PIP5K; PtdIns(4)P-5-kinase; PIKfyve; p235; PIP5K3
Accession No.: Q9Y2I7, NP_055855
Description:
The 1-phosphatidylinositol-4-phosphate 5-kinase (PIP5K3) supports the intracellular PIP and PI 4,5-P(2) pools by generating PIP from PI and PI 4,5-P(2) from PI 4-P. PIP5K3 is involved in endosome-related membrane trafficking. Defects in PIP5K3 are the cause of corneal fleck dystrophy.
Format:
Each vial contains 0.1 ml peptide in deionized water for a final concentration of 1 mg/ml. Use at 5.6 ug/ml for a 100X excess over antibody for maximum blocking effect.
MW: 1935 g/mol
Sequence:
The synthetic peptide used to raise the antibody Cat. No. 200174 is selected from a sequence within the N-term region of human PIP5K3. For blocking experiments, a 10 to 100 fold molar excess to antibody is recommended.
Composition:
C77H127N23O33S1
Purity:
> 80% by HPLC
Solubility:
Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile.
Storage:
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, store at -20°C.
| Is Featured? | No |
|---|
Write Your Own Review